Updated Jul 16, 2026
GADICKE ANSBERT is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $20.03M. Lifetime open-market sales: $8.51M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-01-14 | AKTS | Aktis Oncology, Inc. | P — Open-market purchase | 1.11M | $18.00 | $20.03M |
| 2026-01-14 | AKTS | Aktis Oncology, Inc. | J — Other acquisition / disposition | 1.58M | — | |
| 2026-01-14 | AKTS | Aktis Oncology, Inc. | J — Other acquisition / disposition | 5.91M | — | |
| 2026-01-14 | AKTS | Aktis Oncology, Inc. | J — Other acquisition / disposition | 1.31M | — | |
| 2025-12-04 | HOWL | Werewolf Therapeutics, Inc. | S — Open-market sale [10b5-1] | 83.2K | $0.97 | $81K |
| 2025-12-04 | HOWL | Werewolf Therapeutics, Inc. | S — Open-market sale [10b5-1] | 57.2K | $0.87 | $50K |
| 2025-12-04 | HOWL | Werewolf Therapeutics, Inc. | S — Open-market sale [10b5-1] | 59.3K | $0.89 | $53K |
| 2025-05-13 | ITOS | iTeos Therapeutics, Inc. | S — Open-market sale | 1.03M | $8.06 | $8.32M |
| 2025-03-27 | HOWL | Werewolf Therapeutics, Inc. | S — Open-market sale | 4.4K | $1.05 | $5K |
| 2025-03-27 | HOWL | Werewolf Therapeutics, Inc. | J — Other acquisition / disposition | 50.9K | $0.09 | $5K |
GADICKE ANSBERT is a corporate insider — currently tracked as Insider. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 1 open-market purchases ($20.03M) and 5 open-market sales ($8.51M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live GADICKE ANSBERT profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.